dc.contributor.author | Franco, R. | |
dc.contributor.author | Martínez Pinilla, Eva | |
dc.contributor.author | Navarro, G. | |
dc.date.accessioned | 2019-08-21T07:34:05Z | |
dc.date.available | 2019-08-21T07:34:05Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Expert Opinion on Drug Discovery, 14(4), p. 327-330 (2019); doi:10.1080/17460441.2019.1581169 | |
dc.identifier.issn | 1746-0441 | |
dc.identifier.uri | http://hdl.handle.net/10651/52220 | |
dc.format.extent | p. 327-330 | |
dc.language.iso | eng | |
dc.relation.ispartof | Expert Opinion on Drug Discovery, 14 | |
dc.rights | © 2019 Informa UK Limited, trading as Taylor & Francis Group | |
dc.rights | CC Reconocimiento - No comercial - Sin obras derivadas 4.0 Internacional | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.source | Scopus | |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062969477&doi=10.1080%2f17460441.2019.1581169&partnerID=40&md5=e63fe55248a5a2396fa977bee3031438 | |
dc.title | Why have transgenic rodent models failed to successfully mimic Alzheimer’s disease. How can we develop effective drugs without them? | |
dc.type | journal article | |
dc.identifier.doi | 10.1080/17460441.2019.1581169 | |
dc.relation.publisherversion | http://dx.doi.org/10.1080/17460441.2019.1581169 | |
dc.rights.accessRights | open access | |
dc.type.hasVersion | AM | |